Advanced search
Publication Cover
Clinical, Cosmetic and Investigational Dermatology Volume 16, 2023 - Issue
Submit an article Journal homepage
189
Views
2
CrossRef citations to date
0
Altmetric
CASE REPORT

Pustular Psoriasis in a Patient Treated with Dupilumab for Atopic Dermatitis: A Case Report

Li LiuDepartment of Dermatology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province, People’s Republic of ChinaView further author information
,
Jie ChenDepartment of Dermatology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province, People’s Republic of ChinaView further author information
,
Kangheng TangDepartment of Dermatology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province, People’s Republic of ChinaORCID Iconhttps://orcid.org/0009-0002-5460-5585View further author information
ORCID Icon,
Feng LiDepartment of Dermatology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province, People’s Republic of ChinaView further author information
,
Si LiDepartment of Dermatology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province, People’s Republic of ChinaORCID Iconhttps://orcid.org/0009-0009-5782-2658View further author information
ORCID Icon &
Xiaojie DingDepartment of Dermatology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6442-7829View further author information
ORCID Icon
Pages 2217-2221 | Received 08 Jun 2023, Accepted 01 Aug 2023, Published online: 14 Aug 2023

References

  • Guttman-Yassky E, Krueger JG. Atopic dermatitis and psoriasis: two different immune diseases or one spectrum. Curr Opin Immunol. 2017;48:68–73. doi:10.1016/j.coi.2017.08.008
  • Paolino G, Di Nicola MR, Brianti P, Bianchi VG, Mercuri SR. New onset atopic dermatitis and psoriasis in the same patients under biologic treatments: the role of systemic treatments as a possible trigger. Dermatol Ther. 2022;35(11):e15814. doi:10.1111/dth.15814
  • Barry K, Zancanaro P, Casseres R, Abdat R, Dumont N, Rosmarin D. Concomitant atopic dermatitis and psoriasis-a retrospective review. J Dermatolog Treat. 2021;32(7):716–720. doi:10.1080/09546634.2019.1702147
  • Jo CE, Finstad A, Georgakopoulos JR, Piguet V, Yeung J, Drucker AM. Facial and neck erythema associated with dupilumab treatment: a systematic review. J Am Acad Dermatol. 2021;84(5):1339–1347. doi:10.1016/j.jaad.2021.01.012
  • Mastorino L, Ortoncelli M, Virginia B, et al. Dupilumab-induced urticaria. Dermatol Ther. 2021;34(6):e15117. doi:10.1111/dth.15117
  • Mastorino L, Ortoncelli M, Giura MT, et al. Lichen ruber planus arising during dupilumab treatment for atopic dermatitis. Ital J Dermatol Venerol. 2022;157(5):449–450. doi:10.23736/S2784-8671.21.07070-5
  • Harb H, Chatila TA. Mechanisms of dupilumab. Clin Exp Allergy. 2020;50(1):5–14. doi:10.1111/cea.13491
  • Thibodeaux Q, Smith MP, Ly K, Beck K, Liao W, Bhutani T. A review of dupilumab in the treatment of atopic diseases. Hum Vaccin Immunother. 2019;15(9):2129–2139. doi:10.1080/21645515.2019.1582403
  • Mastorino L, Viola R, Panzone M, et al. Dupilumab induces a rapid decrease of pruritus in adolescents: a pilot real-life study. Dermatol Ther. 2021;34(6):e15115. doi:10.1111/dth.15115
  • Mastorino L, Rosset F, Gelato F, et al. Chronic pruritus in atopic patients treated with dupilumab: real life response and related parameters in 354 patients. Pharmaceuticals. 2022;15(7):883. doi:10.3390/ph15070883
  • Guimarães PM, Scavuzzi BM, Stadtlober NP, et al. Cytokines in systemic lupus erythematosus: far beyond Th1/Th2 dualism lupus: cytokine profiles. Immunol Cell Biol. 2017;95(9):824–831. doi:10.1038/icb.2017.53
  • Mirza FN, Wang A, Ramachandran SM, Damsky W, Cohen JM. Dupilumab-induced phenotype switch from atopic dermatitis to psoriasis is characterized by de novo interleukin-17A expression: a case report. Br J Dermatol. 2021;185(2):432–434. doi:10.1111/bjd.20064
  • Brumfiel CM, Patel MH, Zirwas MJ. Development of psoriasis during treatment with dupilumab: a systematic review. J Am Acad Dermatol. 2022;86(3):708–709. doi:10.1016/j.jaad.2021.05.013
  • Safa G, Paumier V. Psoriasis induced by dupilumab therapy. Clin Exp Dermatol. 2019;44(3):e49–e50. doi:10.1111/ced.13901
  • Tracey EH, Elston C, Feasel P, Piliang M, Michael M, Vij A. Erythrodermic presentation of psoriasis in a patient treated with dupilumab. JAAD Case Rep. 2018;4(7):708–710. doi:10.1016/j.jdcr.2018.05.014
  • Zhong X, Li Y, Gao Y, et al. Pustular psoriasis appearing in a Chinese woman treated with dupilumab for atopic dermatitis: a case report. Dermatol Ther. 2022;35(11):e15851. doi:10.1111/dth.15851
  • Fowler E, Silverberg JI, Fox JD, Yosipovitch G. Psoriasiform dermatitis after initiation of treatment with dupilumab for atopic dermatitis. Dermatitis. 2019;30(3):234–236. doi:10.1097/DER.0000000000000481
  • Marrakchi S, Guigue P, Renshaw BR, et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med. 2011;365(7):620–628. doi:10.1056/NEJMoa1013068
  • Cohen JN, Bowman S, Laszik ZG, North JP. Clinicopathologic overlap of psoriasis, eczema, and psoriasiform dermatoses: a retrospective study of T helper type 2 and 17 subsets, interleukin 36, and β-defensin 2 in spongiotic psoriasiform dermatitis, sebopsoriasis, and tumor necrosis factor α inhibitor-associated dermatitis. J Am Acad Dermatol. 2020;82(2):430–439. doi:10.1016/j.jaad.2019.08.023

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.